Coverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare Part D Program.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33057641.
- Also identified by DOI 10.1001/jamanetworkopen.2020.20969 and PMC identifier 7563069.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study assesses drug coverage, formulary restrictions, median retail prices, and annual out-of-pocket costs associated with commonly used insulin products across Medicare Part D plans.
Medical subject headings
- Diabetes Mellitus, Type 2
- Health Expenditures
- Hypoglycemic Agents
- Medicare Part D
- Sodium-Glucose Transporter 2 Inhibitors